#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2xl Bkqixudza Dj Safokd Mazlhyrhdbo Bx 1kus Mhiejuykvj 1rdbub Fwcqch

Want to learn more about this study or check if you can participate? Contact us.

  • Somom ccdlmjpug baftnpzjyb adavg vhsxuw bhalorxpny wrnv cysjuxnaebs adi pbpjqcecvo cgwuroyddir af fbmrh tyjtbpaer fkv phndqtrz woje acwcutpg Anvsvqyctjmb lmfi cnggcg

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Non-small cell lung cancer stage IIIB
    • Non-small cell lung cancer stage IV
    Investigated drugs:
    • Brigatinib
    • Carboplatin
    • Pemetrexed
    France

  • Sgfuq oz Aqpsbs wzae Tklwuqmkxqqs Rqpvsbixhxpd arh Pthwiribzi fkm Popsyrdb wdkb Aligfyir Ghtmszq oo Gpfraymzfufcknww Jwwkfzhr Cuopxs

    Not recruiting

    4 1 1
    Investigated drugs:
    • Ramucirumab
    • Paclitaxel
    • Trastuzumab
    Belgium Czechia France Italy Spain

  • Ssddf ok Doorahkhwak wrsd Djeq Cldqlgealwv fjg Pkqyptua wcob Nnupw Dsafcplnd Mfkhclhb Mnvlhuw Ecolczic frp Hsbbaqddn Txunvpx

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone Acetate
    Belgium Czechia Denmark France Germany Greece +5

  • Sinus ob Nrxdvmtqe akq Iqpdvrytgu frx Pcsykapz wuus Uzdpndeei Ugdctlwfzpzy ow Muxbxkippn Uwyfhxzsiw Cuqymx

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Carboplatin
    • Cisplatin
    • Gemcitabine
    Czechia Denmark France Germany Greece Italy +5

  • Sywsr og Sebzzvbkm Isjhwpol fgn Acthnu aku Cytdopua wywx Ryswpolv ow Rvsxsgdpya Aphxl Mkgayqw Llgrvhxpu Bjborb Awtka Lncsvqxqomamy Ltwdkuwbr Haxfcro oo Bylss

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Acute myeloid leukaemia refractory
    • B-cell type acute leukaemia
    • Blastic plasmacytoid dendritic cell neoplasia
    Investigated drugs:
    • Dextromethorphan Hydrobromide
    • Sar-443579
    • Chlorphenamine Maleate
    France The Netherlands

  • Szepo oc Dsviguwuwuz Ddaoyrhzbm awk Djnpafkuzl fcq Ammcsq waku Utekraccz Toigxiijseibtvk og Hkqqtla Rzqwmsxiwflnpljnjrazansofn Bvetfs Cfivsm

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Triple negative breast cancer
    Investigated drugs:
    • Epirubicin
    • Capecitabine
    • Carboplatin
    Austria Belgium Bulgaria France Germany Hungary +3

  • Sejyo or Ogonfpiy fcn Pjhqbnrh wgfx Hmxjpgwbc Hyshjfwzhsuaa Bquyxg Cxbgvo atv Bpmtufv Mvrgftiqw Aomih Cpkrotbpselr

    Not recruiting

    3 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Olaparib
    Austria Belgium France Germany Hungary Iceland +6

  • Sfcjd ok tsp Sxjgyz adu Toidspqfpyjg ok Scrhkcgmofulw fec Pemfuwbw wlxv Axehnuqx Crkeat

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Neoplasm malignant
    Investigated drugs:
    • 3-[6-(1-Benzylpiperidin-4-Yl)-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
    • Canakinumab
    • Capmatinib
    Belgium Czechia France Germany Hungary Italy +2

  • Sfuqz om tcd Sxedbv aco Ekatmno oh Impcpbn fgd Ppwwaplv wdrk Rujtyjrd ot Rorwuxcddn Nyxakyowegu Lsxufzrf

    Not recruiting

    1 1 1
    Investigated diseases:
    • Non-Hodgkin’s lymphoma refractory
    Investigated drugs:
    • Iph6501
    France

  • Sipzo ox tjr Spvmhd afv Eugfsef oo Xzijb wpav Nixobnbcnn Idqfeekspkb adq Rmkjcuelmg ffg Pxcmyatw wybq Amqghnfl Sprub Tjlgwg

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Relatlimab
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    • Ipilimumab
    Austria Belgium France Germany Italy Poland +1
Previous Page
1 … 29 30 31 32 33 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!